Top

Published in:

Open Access 01-12-2017 | Research

Serum thyroid-stimulating hormone and interleukin-8 levels in boys with autism spectrum disorder

Authors: Sarika Singh, Umar Yazdani, Bharathi Gadad, Sayed Zaman, Linda S. Hynan, Nichole Roatch, Claire Schutte, C. Nathan Marti, Laura Hewitson, Dwight C. German

Published in: Journal of Neuroinflammation | Issue 1/2017

Abstract

Background

Autism spectrum disorder (ASD) affects approximately 1 in 68 children in the USA. An ASD blood biomarker may enable early diagnosis and/or identification of new therapeutic targets. Serum samples from ASD and typically developing (TD) boys (n = 30/group) were screened for differences in 110 proteins using a multiplex immunoassay.

Results

Eleven proteins were found that together could confirm ASD with modest accuracy using multiple training and test sets. Two of the 11 proteins identified here were further tested using a different detection platform and with a larger sample of ASD and TD boys. The two proteins, thyroid-stimulating hormone (TSH) and interleukin-8 (IL-8), have been previously identified as putative biomarkers for ASD. TSH levels were significantly lower in ASD boys, whereas IL-8 levels were significantly elevated. The diagnostic accuracy for ASD based upon TSH or IL-8 levels alone varied from 74 to 76%, but using both proteins together, the diagnostic accuracy increased to 82%. In addition, TSH levels were negatively correlated with the Autism Diagnostic Observation Schedule subdomain scores.

Conclusions

These data suggest that a panel of proteins may be useful as a putative blood biomarker for ASD.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (5th ed.) Washington, DC; Author; 2013.

CDC. Prevalence of autism spectrum disorder among children aged 8 years—autism and developmental disabilities monitoring network, 11 sites, United States. MMWR. 2014;63(SS-2):1–21.

O'Roak BJ, Stessman HA, Boyle EA, Witherspoon KT, Martin B, Lee C, Vives L, Baker C, Hiatt JB, Nickerson DA, et al. Recurrent de novo mutations implicate novel genes underlying simplex autism risk. Nat Commun. 2014;5:5595.CrossRefPubMedPubMedCentral

Yuen RK, Thiruvahindrapuram B, Merico D, Walker S, Tammimies K, Hoang N, Chrysler C, Nalpathamkalam T, Pellecchia G, Liu Y, et al. Whole-genome sequencing of quartet families with autism spectrum disorder. Nat Med. 2015;21(2):185–91.CrossRefPubMed

Hewitson L. Scientific challenges in developing biological markers for autism. OA Autism. 2013;1(1):1–7.CrossRef

Glatt SJ, Tsuang MT, Winn M, Chandler SD, Collins M, Lopez L, Weinfeld M, Carter C, Schork N, Pierce K, et al. Blood-based gene expression signatures of infants and toddlers with autism. J Am Acad Child Adolesc Psychiatry. 2012;51(9):934–44. e932.CrossRefPubMedPubMedCentral

Momeni N, Bergquist J, Brudin L, Behnia F, Sivberg B, Joghataei MT, Persson BL. A novel blood-based biomarker for detection of autism spectrum disorders. Transl Psychiatry. 2012;2:e91.CrossRefPubMedPubMedCentral

Mizejewski GJ, Lindau-Shepard B, Pass KA. Newborn screening for autism: in search of candidate biomarkers. Biomark Med. 2013;7(2):247–60.CrossRefPubMedPubMedCentral

Ngounou Wetie AG, Wormwood KL, Russell S, Ryan JP, Darie CC, Woods AG. A pilot proteomic analysis of salivary biomarkers in autism spectrum disorder. Autism Res. 2015;8(3):338–50.CrossRefPubMed

10.

West PR, Amaral DG, Bais P, Smith AM, Egnash LA, Ross ME, Palmer JA, Fontaine BR, Conard KR, Corbett BA, et al. Metabolomics as a tool for discovery of biomarkers of autism spectrum disorder in the blood plasma of children. PLoS ONE. 2014;9(11):e112445.CrossRefPubMedPubMedCentral

11.

Amaral DG. The promise and the pitfalls of autism research: an introductory note for new autism researchers. Brain Res. 2011;1380:3–9.CrossRefPubMed

12.

Schaafsma SM, Pfaff DW. Etiologies underlying sex differences in autism spectrum disorders. Front Neuroendocrinol. 2014;35(3):255–71.CrossRefPubMed

13.

O'Bryant SE, Xiao G, Zhang F, Edwards M, German DC, Yin X, Como T, Reisch J, Huebinger RM, Graff-Radford N, et al. Validation of a serum screen for Alzheimer’s disease across assay platforms, species, and tissues. J Alzheimers Dis. 2014;42(4):1325–35.PubMedPubMedCentral

14.

Pramparo T, Pierce K, Lombardo MV, Carter Barnes C, Marinero S, Ahrens-Barbeau C, Murray SS, Lopez L, Xu R, Courchesne E. Prediction of autism by translation and immune/inflammation coexpressed genes in toddlers from pediatric community practices. JAMA Psychiat. 2015;72(4):386–94.CrossRef

15.

Schwarz E, Guest PC, Rahmoune H, Wang L, Levin Y, Ingudomnukul E, Ruta L, Kent L, Spain M, Baron-Cohen S, et al. Sex-specific serum biomarker patterns in adults with Asperger’s syndrome. Mol Psychiatry. 2011;16(12):1213–20.CrossRefPubMed

16.

Napolioni V, Ober-Reynolds B, Szelinger S, Corneveaux JJ, Pawlowski T, Ober-Reynolds S, Kirwan J, Persico AM, Melmed RD, Craig DW, et al. Plasma cytokine profiling in sibling pairs discordant for autism spectrum disorder. J Neuroinflam. 2013;10:38.CrossRef

17.

Chowdhury F, Williams A, Johnson P. Validation and comparison of two multiplex technologies, Luminex and Mesoscale Discovery, for human cytokine profiling. J Immunol Methods. 2009;340(1):55–64.CrossRefPubMed

18.

Krishhan VV, Khan IH, Luciw PA. Multiplexed microbead immunoassays by flow cytometry for molecular profiling: basic concepts and proteomics applications. Crit Rev Biotechnol. 2009;29(1):29–43.CrossRefPubMed

19.

Belzeaux R, Lefebvre MN, Lazzari A, Le Carpentier T, Consoloni JL, Zendjidjian X, Abbar M, Courtet P, Naudin J, Boucraut J, et al. Measuring blood cytokines in biological psychiatry using commercially available multiplex immunoassays. Psychoneuroendocrinology. 2017;75:72–82.CrossRefPubMed

20.

Burguillos MA. Use of meso-scale discovery to examine cytokine content in microglia cell supernatant. Methods Mol Biol. 2013;1041:93–100.CrossRefPubMed

21.

Breiman L. Random forests. Mach Learn. 2001;45(1):5–32.CrossRef

22.

Graham J. Missing data: analysis and design. New York: Springer; 2012.CrossRef

23.

Curran PJ, West SG, Finch J. The robustness of test statistics to non-normality and specification error in confirmatory factor analysis. Psychol Methods. 1996;1:16–29.CrossRef

24.

Suzuki K, Matsuzaki H, Iwata K, Kameno Y, Shimmura C, Kawai S, Yoshihara Y, Wakuda T, Takebayashi K, Takagai S, et al. Plasma cytokine profiles in subjects with high-functioning autism spectrum disorders. PLoS ONE. 2011;6(5):e20470.CrossRefPubMedPubMedCentral

25.

Masi A, Quintana DS, Glozier N, Lloyd AR, Hickie IB, Guastella AJ. Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis. Mol Psychiatry. 2015;20(4):440–6.CrossRefPubMed

26.

Spratt EG, Granholm AC, Carpenter LA, Boger HA, Papa CE, Logan S, Chaudhary H, Boatwright SW, Brady KT. Pilot study and review: physiological differences in BDNF, a potential biomarker in males and females with autistic disorder. Int Neuropsychiatr Dis J. 2015;3(1):19–26.CrossRefPubMed

27.

Steeb H, Ramsey JM, Guest PC, Stocki P, Cooper JD, Rahmoune H, Ingudomnukul E, Auyeung B, Ruta L, Baron-Cohen S, et al. Serum proteomic analysis identifies sex-specific differences in lipid metabolism and inflammation profiles in adults diagnosed with Asperger syndrome. Mol Autism. 2014;5(1):4.CrossRefPubMedPubMedCentral

28.

Morreale de Escobar G, Obregon MJ. Escobar del Rey F. Role of thyroid hormone during early brain development. Eur J Endocrinol. 2004;151 Suppl 3:U25–37.CrossRefPubMed

29.

Anderson GW, Schoonover CM, Jones SA. Control of thyroid hormone action in the developing rat brain. Thyroid. 2003;13(11):1039–56.CrossRefPubMed

30.

Bernal J. Thyroid hormones and brain development. Vitam Horm. 2005;71:95–122.CrossRefPubMed

31.

Koibuchi N, Iwasaki T. Regulation of brain development by thyroid hormone and its modulation by environmental chemicals. Endocr J. 2006;53(3):295–303.CrossRefPubMed

32.

Hashimoto T, Aihara R, Tayama M, Miyazaki M, Shirakawa Y, Kuroda Y. Reduced thyroid-stimulating hormone response to thyrotropin-releasing hormone in autistic boys. Dev Med Child Neurol. 1991;33(4):313–9.CrossRefPubMed

33.

Yau VM, Lutsky M, Yoshida CK, Lasley B, Kharrazi M, Windham G, Gee N, Croen LA. Prenatal and neonatal thyroid stimulating hormone levels and autism spectrum disorders. J Autism Dev Disord. 2015;45(3):719–30.CrossRefPubMed

34.

Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Van de Water J. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun. 2011;25(1):40–5.CrossRefPubMed

Title: Serum thyroid-stimulating hormone and interleukin-8 levels in boys with autism spectrum disorder
Authors: Sarika Singh
Umar Yazdani
Bharathi Gadad
Sayed Zaman
Linda S. Hynan
Nichole Roatch
Claire Schutte
C. Nathan Marti
Laura Hewitson
Dwight C. German
Publication date: 01-12-2017
Publisher: BioMed Central
Published in: Journal of Neuroinflammation / Issue 1/2017
Electronic ISSN: 1742-2094
DOI: https://doi.org/10.1186/s12974-017-0888-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Serum thyroid-stimulating hormone and interleukin-8 levels in boys with autism spectrum disorder

Abstract

Background

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2017

Peripheral immune tolerance alleviates the intracranial lipopolysaccharide injection-induced neuroinflammation and protects the dopaminergic neurons from neuroinflammation-related neurotoxicity

Targeting the NLRP3 inflammasome to attenuate spinal cord injury in mice

Prophylactic inhibition of neutrophil elastase prevents the development of chronic neuropathic pain in osteoarthritic mice

Retraction Note to: Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in brain of HIV-1 transgenic rats

Primary cilia modulate TLR4-mediated inflammatory responses in hippocampal neurons

Tenuigenin protects dopaminergic neurons from inflammation via suppressing NLRP3 inflammasome activation in microglia